东海证券给予开立医疗“买入”评级，公司简评报告：营收逐季改善，新产品线放量迅速

Group 1 - The core viewpoint of the report is that Donghai Securities has given a "buy" rating for Kaili Medical (300633.SZ) based on several factors [1] Group 2 - Revenue has increased year-on-year, but profit still needs improvement [1] - Gross margin is under pressure, and expenses continue to affect net profit margin [1] - The employee stock ownership plan reflects the management's confidence in the company [1]